Overview

A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients

Status:
Completed

Trial end date:
2016-06-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is for investigation and collection of Aricept safety information with a dose increase on Alzheimer's disease patients.

Details

Lead Sponsor:

Eisai Korea Inc.

Treatments:

Donepezil